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Abstract We have previously shown that the pteridine com- 
pound neopterin stimulates inducible nitric oxide synthase 
(iNOS) gene expression in vascular smooth muscle cells in vitro. 
The mechanisms whereby neopterin exhibits these effects 
remained unclear. The present study demonstrates that neopterin 
induces the translocation of the transcription factor nuclear 
factor-w~B (NF-~B) to the nucleus. Pretreatment of cells with the 
antioxidant pyrrolidine dithiocarbamate completely suppressed 
the effects of neopterin on NF-r,~B activation, iNOS gene 
expression, and nitric oxide release. From these data we conclude 
that neopterin activates the translocation of NF-r,B suhunits to 
the nucleus by modulating the intracellular redox state. This is 
one possible explanation for the impact of neopterin on iNOS 
gene expression. 
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1. Introduction 
Neopterin is a heterocyclic pteridine compound synthesized 
and released in excess by mononcytes/macrophages upon 
stimulation with interferon-~ (IFN-~,) [1]. The production of 
neopterin hereby closely correlates with IFN-y serum concen- 
tration and the activation of cell-mediated immunity [2]. 
Therefore, determination of neopterin levels in body fluids 
has become a valuable diagnostic tool in conditions associated 
with increased activity of the cellular immune system, e.g. 
HIV-infection, autoimmune disease, and certain types of can- 
cer [3,4]. Recent data suggest hat neopterin itself exhibits 
distinct biochemical functions. It was found to enhance the 
effects of cytotoxic reactive oxygen species originating from 
chloramine T and hydrogen peroxide [5,6]. This suggests that 
neopterin may influence biochemical pathways of reactive 
oxygen intermediates, thereby modulating macrophage-in- 
duced cytotoxicity by the induction of oxidative stress. In 
addition, Barak and Gruener [7] described an augmentation 
of tumor necrosis factor-e~ (TNF-a)-production i  peripheral 
blood mononuclear cells and macrophages following simulta- 
neous exposure to neopterin and lipopolysacharide (LPS) de- 
rived from E. coli. In a previous tudy, we could demonstrate 
that neopterin stimulates inducible nitric oxide synthase 
(iNOS) gene expression at the mRNA level with a subsequent 
increase in nitric oxide (NO) production [8]. The biochemical 
mechanism(s) by which neopterin influences NO synthesis re- 
mained unclear. Oxidative stress has been described to acti- 
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vate the cellular transcription factor nuclear factor-~B 
(NF-~:B) in various cell types [9-11]. Since the promotor of 
the iNOS gene in murine macrophages contains two putative 
binding sites for NF-~B [12] it is conceivable that neopterin 
stimulates the transcription of the iNOS gene through activa- 
tion of NF-~:B. In the present study, we investigated the ef- 
fects of neopterin and oxidative stress on NF-~B activation 
and iNOS gene expression i  VSMC in vitro. 
2. Materials and methods 
2.1. Reagents 
Dulbecco's modified Eagle's medium (DMEM) with phenol red was 
purchased from ccPro, Karlsruhe, Germany. DMEM without phenol 
red, L-arginine, collagenase I, dithiothreitol (DDT), EDTA, EGTA, 
glycerol, HEPES, Nonidet P-40, trypsin inhibitor, N-(1-naphthylethyl- 
ene)diamine, I~-NADPH, phenol-chloroform-isoamyl lcohol mixture, 
phenylmethylsulfonyl fluoride (PMSF) and pyrrolidine dithiocarba- 
mate (PDTC) were from Sigma Chemicals, Deisenhofen, Germany. 
Fetal calf serum (FCS), penicillin-streptomycin, trypsin-EDTA, and 
M-MLRV superscript reverse transcriptase w re purchased from Gib- 
co Life Tech., Eggenstein, Germany. Elastase and sulfanilamide were 
from Serva, Heidelberg, Germany. Oligo(dT)la nd dNTP-mix were 
from Amersham Buchler, Braunschweig, Germany. Taq polymerase 
and primer sets were obtained from Biometra, G6ttingen, Germany; 
guanidine isothiocyanate and Tris was from Roth, Karlsruhe, Ger- 
many; nitrate reductase was from Boehringer, Mannheim, Germany. 
Hydrogen peroxide (H202) was purchased from Merck, Darmstadt, 
Germany. Recombinant rat tumor necrosis factor-tt (TNF-et) was 
from IC Chemicals, Ismaning, Germany, neopterin was purchased 
from Schircks Lab., Jona, Switzerland. 
NF-~B p65 antibody (human, mouse, and rat reactive rabbit poly- 
clonal IgG) was purchased from Santa Cruz Biotechnology, Santa 
Cruz, CA. 
2.2. Preparation of rat aortic vascular smooth muscle cells 
Preparation of VSMC from WKY rats was performed as described 
recently [13]. Briefly, the rats were decapitated under ether anesthesia 
and the thoracic aorta was cut out and dissected immediately. VSMC 
were isolated by enzymatic digestion using collagenase I (385 U/ml), 
and elastase (90 U/ml), suspended in DMEM (containing 50 gg/ml 
streptomycin, 50U/ml penicillin, and 10% FCS) and grown in 75 cm 2 
culture flasks (Falcon) in a humidified atmosphere of 95% air/5% 
CO2. For experiments, passages 4 to 12 of subcultured cells were 
used. A total of 5 different cell preparations from WKY was used 
in the present study. 
2.3. Nitrite and nitrate assay 
Synthesis of the stable NO metabolites nitrite and nitrate was de- 
termined in the cell-free culture supernatants incubated for 48 h in 
L-arginine-enriched medium without phenol red. Nitrate was reduced 
to nitrite by nitrate reductase (0.4 U/ml), in the presence of 10 mM 
~-NADPH. Total nitrite accumulation was assayed by the Griess 
reaction [14]. 
2.4. RNA isolation and polymerase chain reaction 
9 h after stimulation cells were washed with sterile PBS and lysed 
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with 4 M guanidine isothiocyanate containing 0.1 M 2-mercaptoetha- 
nol. Total RNA was isolated by acid phenol-chloroform extraction 
according to the method of Chomczynski and Sacchi [15], redissolved 
in water and the concentration determined photometrically at a wave- 
length of 260 nm. 1 ~tg total RNA was reverse-transcribed into first 
strand cDNA using oligo(dT)15 as primer for reverse transcriptase 
(RT). RT-generated cDNA encoding for rat iNOS was amplified 
using polymerase chain reaction (PCR) as described recently [8]. Ex- 
pression of the housekeeping gene glyceraldehyde-3-phosphate dehy- 
drogenase (GAPDH) served as control, RNA with no GAPDH band 
was excluded from further investigations. 
For quantitation of iNOS cDNA, a competitive PCR was per- 
formed using a DNA fragment derived from the viral oncogene V- 
erb B to which the iNOS primer template sequences have been added 
(Competitive DNA MIMIC, Clontech, Heidelberg, Germany), as de- 
scribed by Siebert and Larrick [16]. Increasing quantities of the stand- 
ard DNA were spiked into a series of PCR reaction tubes containing 
equal amounts of iNOS cDNA. Following PCR, the amount of prod- 
ucts generated from the standard DNA as well as from the iNOS 
cDNA were compared. The initial amounts of iNOS cDNA and com- 
petitor DNA were assumed to be equal in those reactions where the 
molar ratio of iNOS and standard products was judged to be equal by 
densitometric analysis of the scanned photographs (Imaging densito- 
meter GS 670, BioRad GmbH, Miinchen, Germany) with regard to 
the different amount of ethidium bromide intercalation according to 
the length of the fragments. Results are expressed as amol iNOS- 
cDNA/gg total RNA taking into consideration that 1 gl of the 25 
gl RT reaction yield was used per quantitative PCR. Oligonucleotide 
primers for iNOS and internal standard were: 5' CCCTTCCG- 
AAGTTTCTGGCAGCAGG 3' (upstream), and 5' GGCTGTCA- 
GAGCCTTGTGCCTTTGG 3' (downstram) corresponding to the 
murine macrophage iNOS [17]. Oligonucleotide primers for GAPDH 
were: 5' GCAGGGGGAGCCAAAAGGG 3' (upstream) and 5' 
TGCCAGCCCCAGCGTCAAAG 3' (downstream) corresponding 
to the human GAPDH gene [18]. 
2.5. Preparation of nuclear extracts 
Nuclear extracts were prepared according to a method escribed by 
Hoppe-Seyler t al. [19]. Following a 2 h incubation, cells were rinsed 
with cold phosphate-buffered saline solution and lysed directly on the 
culture dishes in 1 ml cold lysis buffer (0.6% Nonidet P-40, 150 mM 
NaC1, 10 mM Tris pH 7.9, 1 mM EDTA). Lysed cells were trans- 
ferred into a 2 ml Eppendorf tube and incubated for 5 min on ice. The 
nuclei were pelleted (1250×g, 4°C, 5 min), the supernatant was dis- 
carded, and nuclear proteins were extracted in 100 ~tl extraction buffer 
(420 mM NaCI, I0 mM HEPES pH 7.9, 0.1 mM EGTA, 0.1 mM 
EDTA, 1.5 mM MgC12, 0.5 mM DTT, 0.5 mM PMSF, 25% glycerol) 
on ice for 20 min. Cellular debris was removed by centrifugation 
(1250 × g, 4°C, 5 min) and the supernatant containing nuclear protein 
was stored at -70°C. 
2.6. Western blot analysis 
NF-nB from nuclear extracts was detected by immunoblotting. 
Sample protein content was determined using bovine serum albumin 
as a standard according to the method of Bradford [20]. Equal protein 
amounts from each sample (5 ~tg) were separated by SDS-PAGE 
using an 8% acrylamide gel as described by Laemmli [21]. 
Separated proteins were transferred on a nitrocellulose membrane 
for 1 h at 250 mA by using a Bio-Rad Transblot (BioRad GmbH, 
Miinchen, Germany) apparatus. Membranes were then incubated for 
12 h with a polyclonal rabbit anti NF-nB antibody (dilution: 1/200) 
corresponding to amino acids 531-550 at the carboxy terminus of the 
NF-wB p65 subunit. An anti-rabbit secondary antibody was used to 
visualize the NF-r~B-antibody complex by an alkaline phosphatase 
reaction. 
2. Z Statistical analysis 
The results in Table 1 are expressed as mean values + standard error 
of the mean (S.E.M.). To test for significance of differences between 
the mean value of a control vs. the mean value of treated cells, Stud- 
ent's t-test was used. P values < 0.05 were considered to be signifi- 
cant. 
3. Results 
Fig. 1 shows NF-~cB in nuclear extracts of VSMC detected 
by Western blot analysis. 2 h stimulation of cells with neop- 
terin (20 ~tM), TNF-a  (500 U/ml), and H202 (300 laM) re- 
sulted in enhanced nuclear uptake of  NF-~B whereas it was 
undetectable under control conditions. Pretreatment of cells 
with PDTC for 2 h completely suppressed the effects of neop- 
terin and H202 on NF-wB activation but a weak NF-~B sig- 
nal was still detectable in those cells exposed to PDTC and 
TNF-a .  Fig. 2 summarizes the results of the qualitative ana- 
lysis of iNOS mRNA expression following 9 h stimulation. 
Neopterin, TNF-c~, and H202 increased iNOS mRNA expres- 
sion while PDTC reduced the TNF-a-dependent stimulation. 
No iNOS mRNA was found in unstimulated cells (C) and in 
VSMC treated with PDTC prior to the addition of either 
neopterin or H202. The results of the quantitation of iNOS 
cDNA from cells incubated with neopterin, TNF-a ,  PDTC 
plus TNF-a ,  and H202 for 9 h are presented in Fig. 3. Neop- 
terin enhanced iNOS mRNA expression to 62.5 amol cDNA/  
~tg total RNA. TNF-a  treatment resulted in a stronger induc- 
tion of iNOS cDNA production (312.5 amol/~tg total RNA), 
whereas H202 was a weaker stimulus of iNOS gene expression 
(iNOS cDNA concentration was 12.5 amol/~tg total RNA). In 
cells preincubated with the antioxidant PDTC for 2 h, only 
the subsequent addition of TNF-~ led to measurable amounts 
of iNOS cDNA, but the level (62.5 amol/~tg total RNA)  was 
considerably lower compared to TNF-~ treatment alone. Ni- 
trite/nitrate (NO~-/NO~-) determinations in cell-free culture 
supernatants following 24 h incubation periods are summa- 
rized in Table 1. Stimulation of iNOS gene expression by 
neopterin, TNF-a ,  and H202 was accompanied by an increase 
in nitrite/nitrate concentrations as compared to unstimulated 
controls, thus indicating that VSMC were activated to pro- 
duce and release NO. In contrast, NO~-/NO~- levels were not 
significantly augmented in cells that had been preincubated 
with PDTC before the addition of neopterin or HzO2. 
Although nitrite/nitrate concentration was raised significantly 
Table 1 
Nitrite/nitrate l vels measured as accumulated nitrite in cell-free culture supernatants following 24 h incubations 
Nitrite (nmol/lO 6 cells) 
Unstimulated controls 
Neopterin (20 ~tM) 
PDTC" (150 I.tM)+neopterin (20 btM) 
Tumor necrosis factor-c~ (500 Ulml) 
PDTC a (150 I.tM)+tumor necrosis factor-~ (500 U/ml) 
Hydrogen peroxide (300 I.tM) 
PDTC a (150 I.tM)+hydrogen peroxide (300 gM) 
2.62 _+ 0.33 
9.71 _+ 1.62 b 
3.64 _+ 0.90 
71.12+3.82 b 
8.57 + 1.24 b
8.99 _+ 0.63 b 
2.55_+0.27 
Data are expressed as means + S.E.M. (n--8). 
~Pyrrolidine dithiocarbamate (PDTC) was added 2 h prior to stimulation of cells with other substances. 
bp < 0.05 as compared to unstimulated cells. 
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following coincubation of cells with PDTC plus TNF-c~ 
(P < 0.05 as compared to control), this increase in NO meta- 
bolite concentration was only a fraction of that measured in 
supernatants of cells exposed to TNF-a alone. 
4. D iscuss ion  
In a recent study we could show that the heterocyclic pter- 
idine compound neopterin stimulates iNOS gene expression 
and nitric oxide release in cultured vascular smooth muscle 
cells [8]. The biochemical mechanism(s) of these effects re- 
mained unclear. The present data demonstrate hat the same 
amount of neopterin (20 ktM) activates translocation of NF- 
~B to the nucleus of VSMC in vitro. Activation of NF-+cB is 
most likely an important pathway for the transcriptional in- 
duction of iNOS by various immunostimulants. The promotor 
of the murine gene coding for iNOS contains at least two 
elements homologous with consensus sequences for the bind- 
ing of NF-~B [12]. Of these two putative NF-~B binding sites 
the downstream oriented has been demonstrated to confer 
LPS inducibility of iNOS [22]. In unstimulated cells, nuclear 
uptake of NF-~:B is suppressed by inhibitory subunits called 
I~B proteins. The NF-~cB activation process requires the re- 
lease of I~B from the cytoplasmic complex [23]. In our experi- 
ments, TNF-a which induces the production of free radicals 
[24-26] as well as H202 led to NF-~B activation, iNOS gene 
expression, and NO release in VSMC. Reactive oxygen species 
may modulate the cellular edox state, which has been linked 
to NF-~B activation [27]. It is of note that TNFa and H202 
seem to induce a slower migrating form of NF-~:B than neop- 
terin which might indicate different states of NF-~B phos- 
phorylation (Fig. 1). This observation clearly needs further 
investigation. 
,.- .,, .~13. • . . . .  ,~• , 
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Fig. 1. Western Blot analysis of nuclear factor-+cB (NF-r~B) in nucle- 
ar extracts of vascular smooth muscle cells following 2 h incubation 
with: 20 IxM neopterin (NEO), 150 ~tM pyrrolidine 
dithiocarbamate*+20 laM neopterin (PDTC+NEO), 500 U/ml tumor 
necrosis factor-a (TNF-a), 150 IxM pyrrolidine dithiocarba- 
mate*+500 U/ml tumor necrosis factor-a (PDTC+TNF-a), 300 ktM 
hydrogen peroxide (H202), and 150 ktM pyrrolidine 
dithiocarbamate*+300 gM hydrogen peroxide (PDTC+H202), re- 
spectively. Lane C shows the result of a control experiment in unsti- 
mulated cells. Lane P indicates bovine serum albumin that served as 
a molecular mass marker (64.2 kDa). Lane P was separately stained 
with Ponceau Red. Results are representative of three different ex- 
periments. *Pyrrolidine dithiocarbamate (PDTC) was added 2 h 
prior to stimulation of cells with other substances. 
A 
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Fig. 2. (A) Qualitative PCR analysis of iNOS mRNA expression de- 
tected as iNOS cDNA (fragment size: 498 base pairs) following 9 h 
incubations of vascular smooth muscle cells with: 20 ~tM neopterin 
(NEO), 150 ktM pyrrolidine dithiocarbamate*+20 I.tM neopterin 
(PDTC+NEO), 500 U/ml tumor necrosis factor-ct (TNF-t~), 150 ~M 
pyrrolidine dithiocarbamate*+500 U/ml tumor necrosis factor-ct 
(PDTC+TNF-c~), 300 gM hydrogen peroxide (H202), and 150 p.M 
pyrrolidine dithiocarbamate* +300 I.tM hydrogen peroxide 
(PDTC+H202), respectively. Lane C shows the result of a control 
experiment in unstimulated cells, lane M indicates a size standard 
(100 base pair ladder). (B) The lower part of the figure shows the 
corresponding GAPDH bands (fragment size: 567 base pairs). Re- 
sults are representative of three different experiments. *Pyrrolidine 
dithiocarbamate (PDTC) was added 2 h prior to stimulation of cells 
with other substances. 
Our findings imply that vascular smooth muscle cells re- 
spond to oxidative stress with an increased NO synthesis 
mediated by NF-~:B. However, the possible connection be- 
tween neopterin and oxidative stress is discussed controver- 
sially. In vitro, the amount of H202 released by murine 
macrophages correlates with the amount of neopterin released 
by the cells upon stimulation with IFN- 7 [28]. On the other 
hand, recent data suggest that neopterin itself potentiates the 
effects of reactive oxygen intermediates originating from H202 
and chloramine-T [5,6]. In contrast, Kojima et al. [29] found a 
scavenging activity by neopterin for superoxide anions. This 
might indicate that H202 or H202-derived reactive oxygen 
species are responsible for the NF-lcB translocation but not 
superoxide anions. To evaluate our hypothesis that the effects 
of neopterin on NF-~B activation and iNOS gene expression 
are mediated by mechanisms of oxidative stress, a second set 
of experiments was performed in which VSMC were pre- 
treated with PDTC for 2 h prior to the addition of neopterin, 
TNF<t, or H202. PDTC is a potent antioxidant that has been 
shown to block the NF-~B activation induced by reactive 
oxygen species like H202 or by TNF-a in Jurkat T cells 
[27]. Furthermore, PDTC was able to inhibit iNOS gene ex- 
pression mediated by NF-~B activation in different cell lines 
[30,31] and in rat aortic strips [32]. In our study, PDTC pre- 
incubation strongly suppressed the effects of neopterin, TNF- 
a, and H202 on nuclear uptake of NF-KB. 
This was accompanied by a comparable reduction of iNOS 
cDNA concentration a d NQ-/NO 3 release, respectively. In 
conclusion, our data suggest hat, at least under our experi- 
mental conditions, neopterin activates NF-~B by modulating 
the production and/or the effects of reactive oxygen intermedi- 
ates in VSMC. This might be one of the biochemical mechan- 
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Fig. 3. Quantitative PCR analysis of iNOS mRNA expression de- 
tected as iNOS cDNA (fragment size: 498 base pairs) following 9 h 
incubations of vascular smooth muscle cells with: 20 ~tM neopterin 
(NEO), 150 IxM pyrrolidine dithiocarbamate+20 ~tM neopterin 
(PDTC+NEO), 500 U/ml tumor necrosis factor-a (TNF-~), 150 ~tM 
pyrrolidine dithiocarbamate+500 U/ml tumor necrosis factor-a 
(PDTC+TNF-a), 300 I.tM hydrogen peroxide (H202), and 150 ~tM 
pyrrolidine dithiocarbamate+300 ~tM hydrogen peroxide 
(PDTC+H202), respectively. Samples were quantitated as described 
in Section 2. Results are representative of three different experi- 
ments. 
ism(s) whereby neopterin influences iNOS gene expression and 
nitric oxide production. 
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